Literature DB >> 4199921

The prognosis following surgical removal of mastocytomas in dogs.

D E Bostock.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4199921     DOI： 10.1111/j.1748-5827.1973.tb06891.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN： 0022-4510            Impact factor:   1.522


× No keyword cloud information.
  14 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours.

Authors:  R Preziosi; G Sarli; M Paltrinieri
Journal:  Vet Res Commun       Date:  2006-12-29       Impact factor: 2.459

3.  Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Authors:  C Robat; C London; L Bunting; L McCartan; N Stingle; K Selting; I Kurzman; D M Vail
Journal:  Vet Comp Oncol       Date:  2011-01-31       Impact factor: 2.613

4.  The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

Authors:  Joshua D Webster; Vilma Yuzbasiyan-Gurkan; John B Kaneene; RoseAnn Miller; James H Resau; Matti Kiupel
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

5.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

6.  Multiple cutaneous mast cell tumors in a dog: a case report and brief review.

Authors:  D R Pelt; J D Fowler; F A Leighton
Journal:  Can Vet J       Date:  1986-07       Impact factor: 1.008

7.  Lomustine (CCNU) and prednisone chemotherapy for high-grade completely excised canine mast cell tumors.

Authors:  Jennifer K Hay; Victoria S Larson
Journal:  Can Vet J       Date:  2019-12       Impact factor: 1.008

8.  Uterine mast cell tumor: a clinical and cytohistopathological study.

Authors:  Ali Mohammad Bahrami; Fariba Khaki; Shahram Zehtabian; Javad Cheraghi; Mehdi Rashnavadi; Mohammad Reza Hafezi Ahmadi; Mostafa Naderafif; Soheil Javaherypour; Siamak Mohsenzadeh; Ehsan Hosseini; Hamed Masoudi; Mehdi Pourzaer
Journal:  J Ovarian Res       Date:  2014-11-07       Impact factor: 4.234

9.  Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

Authors:  J H Burton; R O Venable; D M Vail; L E Williams; C A Clifford; S M Axiak-Bechtel; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2015-06-25       Impact factor: 3.333

10.  Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.

Authors:  Joshua D Webster; Vilma Yuzbasiyan-Gurkan; Douglas H Thamm; Elizabeth Hamilton; Matti Kiupel
Journal:  BMC Vet Res       Date:  2008-08-13       Impact factor: 2.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.